$ASTI Investor Information

Kestrel's Financial Rollercoaster Continues Here's the deal with Kestrel Group, folks. They just dropped their Q3 2026 financials, and it's a mixed bag. The top line's looking solid with total revenues hitting $4.8 million, riding high on a 203% jump in Program Services fee income. But dig a little deeper, and there's a $16.4 million net loss staring us in the face....

Nickel's Bright Future in Industry Growth Diving right into the mix, the nickel market is an ever-evolving beast that's seen more twists and turns than a roller coaster ride. As it sails towards an anticipated worth of $80.68 billion by 2031, it's driven by a medley of demands from stainless steel production to electric vehicle battery innovation. Electric Vehicles Fuel...

Investing in Koppers: A Mixed Bag in Q3 Well, it appears Koppers (NYSE: KOP) is doing a bit of a dance this quarter—some smooth steps, but a few stumbles in the rhythm when it comes to margins. The hardwood numbers tell an interesting tale, so let's break it down. Sales Edge Up, But Margins Suffer Koppers clocked in net sales of $499.1 million for the third quarter of...

Small Businesses Find Their Voice with Ripple & AOF Accolades are sweet, but when they highlight real stories of change, you've got something more than just a shiny trophy. That's what's cooking over at Ripple and Accion Opportunity Fund (AOF) with their 'Unlocking Opportunity Together' campaign snagging a Bronze Anthem Award in the Humanitarian Action & Services...

A New Frontier in 3D Printing The silicon buzz surrounding ELEGOO's unveiling at Formnext 2026 is about as palpable as the smell of hot silicone on a fresh print. This Shenzhen-based company ain't sitting on past laurels. Nope, they're pushing the envelope with a bunch of spiffy new 3D devices, right from FDM printers to the all-in-one M1 Ultra scanner. Spotlight on Key...

Incisionless Relief: A New Dawn for Neurological Care? Imagine being able to shed a neurological burden with nothing more than sound waves. That's exactly where we're heading with MedStar Health's latest offering. They're rolling out incisionless, MRI-guided ultrasound technology targeting essential tremor and Parkinson's disease. This isn't just tinkering under the hood;...

Diving Deep into Supply Chain Disturbances Accrete's making waves in the supply chain game with a fresh move that's got the sector talking. Partnering with TenderAlpha, they're pulling strings to provide federal agencies with deeper supply chain insights. You see, Accrete, the brainy bunch driving Knowledge Engines, is sharpening its focus on those unseen tangles in the...

HSBC Raises Stake in Its Own Game See folks, when HSBC announces it's bumping up the ceiling on buying back its own securities, you know there's a game afoot in the capital management arena. They raised the offering to snag up these $3 billion 6% perpetuals from $1 billion up to a hefty $1.5 billion. It's like they’re saying, 'Hey, let’s tighten the belt and make sure...

MNTN's Recent Earnings Call Sparks Controversy Alright, we're back at that crossroads where the rubber meets the road for MNTN's investors. After certain company revelations, folks are wondering what's in the pipeline and how deep this muck goes. Seems like some proverbial skeletons just can't stay in the closet. Dissecting the Earnings Disappointment Here's the scoop:...

An Investment That's Turning Heads Alright, here's a curveball for ya. Zylox-Tonbridge and GL Capital are throwing down a cool HK$1.482 billion into LifeTech Scientific, aiming for a high-stakes play in the vascular and structural heart field. This isn't just peanuts or pocket change; it's a concerted push to carve out a new landscape in China with something akin to a...

CoreWeave's Historic Achievement in AI Benchmarking In an impressive feat, CoreWeave, in collaboration with NVIDIA and IBM, has achieved remarkable results on the MLPerf Training v5.0. Utilizing nearly 2,500 NVIDIA GB200 GPUs, this submission marks the largest ever recorded in the history of these benchmarks. The achievement underscores the robust capabilities of...

Bristol Myers Squibb Prep for J.P. Morgan Conference Bristol Myers Squibb (NYSE: BMY), a leading biopharmaceutical company, is gearing up for an important presentation at the renowned J.P. Morgan’s Annual Healthcare Conference. This event is a key opportunity for industry leaders and innovators to share insights, discoveries, and strategies that pave the way for the...

Gerdau's Latest Earnings: A Mixed Bag Gerdau’s latest earnings report hit the table, and folks, it’s a bit of a mixed bag. They dropped their Q4 results on February 23, 2026, and things aren't looking rosy. EPS came in at a whopping negative $0.12—yeah, you read that right—against an estimated $0.11. A staggering -209.09% miss. I mean, talk about a shareholder...

Recent Market Trends After facing significant losses earlier in the week, markets managed a noteworthy recovery. However, this bounce back didn’t fully compensate for the declines, and concerns linger around potential ‘bull traps’ specifically within the S&P 500. The technical indicators for this major index remain mixed, as momentum indicators like stochastics have...

Transforming Leadership: Never Fire Anyone Mark Morgenfruh has partnered with GetHRready to unveil a pioneering book titled Never Fire Anyone. This innovative leadership model emphasizes the importance of trust, empathy, and strong relationships. The book is now available in both paperback and digital formats. A Unique Perspective on Leadership In a world where immediate...